How Does Teixobactin Work? Mechanism of Action, Per the Research

What Teixobactin Is, as Described in the Literature

Teixobactin is a cyclic depsipeptide antibacterial natural product with activity reported against Gram positive bacteria. A 2024 Nature review of natural product antibiotics grouped teixobactin with molecules that act on targets which are not proteins and discussed why that feature drew attention in antibiotic discovery programmes (PMID 39085542). A 2020 review in the Journal of Medicinal Chemistry framed teixobactin as a paving stone toward a new class of antibiotics, that is, a research lead and a scaffold for analogue chemistry rather than a finished medicine (PMID 32520557).

Almost all mechanism data in the cited record came from in vitro assays, bacterial culture, model membranes and biophysical spectroscopy such as solid state nuclear magnetic resonance. The sections below label the evidence type for each claim and separate what the cited studies measured directly from what reviews proposed as an interpretation. This page is for educational purposes only and is not medical advice; consult a licensed physician with questions about any compound or condition.

The Established Target: Lipid Linked Cell Wall Precursors

A bacterial lipid, not a host receptor

Teixobactin is not described in the cited literature as acting through a mammalian receptor or an intracellular signalling cascade in human cells. Its binding partner is a bacterial membrane anchored molecule: a 2020 Nature Communications study using solid state NMR in cellular membranes reported that teixobactins target lipid II, the lipid linked precursor used to build peptidoglycan (PMID 32503964). The 2020 Journal of Medicinal Chemistry review likewise centred its mechanistic discussion on binding to cell wall precursor molecules rather than on inhibition of a specific enzyme (PMID 32520557).

Which part of the precursor is recognised

A 2018 Chemical Science study probed key elements of teixobactin and lipid II interactions inside membranes and reported that recognition involved the pyrophosphate and sugar region of the precursor, with the molecule acting within the lipid bilayer environment rather than in free solution (PMID 30210775). That membrane context mattered for interpretation, because researchers in that study examined the interaction in bilayers rather than in detergent or buffer alone (PMID 30210775).

Assembly, not simple one to one binding

The 2020 Nature Communications work reported that teixobactins did more than occupy a precursor molecule: the study described supramolecular assembly of antibiotic and target at the membrane surface and associated disturbance of the membrane itself (PMID 32503964). This two part picture, precursor sequestration plus membrane level effects, is the most detailed mechanistic account in the verified set and was obtained in membrane systems rather than in animals or humans (PMID 32503964).

Downstream Physiology in the Bacterial Cell

The consequences described in the cited work follow from interrupting the supply line for the cell wall. Because peptidoglycan assembly depends on the lipid linked precursor crossing and being processed at the membrane, sequestering that precursor stalls wall construction, as discussed in the 2020 review of teixobactin pharmacology and chemistry (PMID 32520557).

• Precursor capture. Solid state NMR work reported binding of teixobactins to lipid II in cellular membranes (PMID 32503964), with the pyrophosphate sugar motif identified as a key recognition element in bilayers (PMID 30210775).
• Loss of wall building capacity. The 2020 review described inhibition of cell wall biosynthesis as the central activity of this compound class (PMID 32520557).
• Membrane level effects. The 2020 study reported that the assembled antibiotic and target structures were associated with damage at the membrane, adding a second layer to the mechanism (PMID 32503964).
• Envelope stress signalling in the target cell. A 2023 Molecular Microbiology study described the CroRS two component system as a master regulator of cell envelope homeostasis that conferred antimicrobial tolerance in Enterococcus faecalis (PMID 37475106).
• Bioenergetic context. A 2020 review examined the intersection of bacterial bioenergetics and antibiotic discovery, a framework relevant to agents that act at the membrane (PMID 33705287).

Signalling: How the Bacterium Responds

Signalling in this story belongs to the bacterium rather than to a host cell. The 2023 Molecular Microbiology study reported that the CroRS two component system governed cell envelope homeostasis and that this regulatory pathway contributed to tolerance of antimicrobials in Enterococcus faecalis (PMID 37475106). Two component systems of this kind sense envelope damage and change gene expression in response, so studies of cell wall active agents often examine them when explaining why killing is incomplete in some populations (PMID 37475106).

Structure Activity Work: Which Parts of the Molecule Matter

Synthetic chemistry has been used to test which structural features are required for activity, which indirectly maps the pharmacophore that engages the target. A 2020 review in the Annals of the New York Academy of Sciences summarised total synthesis routes and structure activity relationships for teixobactin and the analogue series derived from them (PMID 31792983).

• Ring chemistry. Researchers prepared analogues in which the macrocycle was rebuilt with a total lactam ring and reported antibacterial activity for those compounds in vitro (PMID 38116416).
• Tail stereochemistry. A 2024 Journal of Organic Chemistry study described teixobactin swapmers carrying l tail stereochemistry and reported that antibiotic activity was retained (PMID 39344830).
• Systematic variation. The 2020 synthesis and structure activity review catalogued how analogue series were used to identify which residues could be varied and which were sensitive to change (PMID 31792983).

Taken together, this chemistry literature is mechanistic evidence of an indirect kind: the fact that certain substitutions preserved activity while the overall scaffold was retained is consistent with binding driven by the macrocyclic region and the amphipathic architecture described in the membrane studies (PMID 30210775, PMID 39344830).

Comparison With Other Agents That Bind Cell Wall Precursors

Teixobactin is not the only molecule described as acting on lipid linked precursors, and comparisons help clarify what is specific to it. A 2016 Journal of the American Chemical Society study on the mechanism of action of lysobactin, another non ribosomal depsipeptide, reported interference with peptidoglycan biosynthesis through engagement of cell wall precursor molecules (PMID 26683668). In the lantibiotic class, a 2024 ACS Chemical Biology study described an engineered nisin analogue bearing a hydrophobic moiety at position 17 that selectively inhibited Enterococcus faecium strains, illustrating how changes to membrane interacting elements can shift the spectrum of a lipid II binding peptide (PMID 39254256).

Established Mechanism Versus Proposed Mechanism

Tolerance and Resistance Findings: What Studies Report

The widely repeated claim about this compound class concerns resistance rather than side effects in humans. The 2024 Nature review discussed natural products that engage targets other than proteins and the argument that such targets are harder for bacteria to alter (PMID 39085542). A 2025 study in Antimicrobial Agents and Chemotherapy complicated that picture: the study reported that prolonged exposure to teixobactin generated cross tolerance to other cell wall targeting antimicrobials in Enterococcus faecalis (PMID 41251371). Researchers studying the same species reported that the CroRS two component system acted as a master regulator of envelope homeostasis and conferred antimicrobial tolerance, offering one route by which bacterial populations survive cell envelope attack without classical resistance mutations (PMID 37475106).

Tolerance and resistance are distinct concepts in this literature: the 2025 culture study described tolerance that extended across agents sharing a cell wall target (PMID 41251371), which is a different observation from a change in minimum inhibitory concentration driven by a mutated binding site as discussed for protein targets in the 2024 review (PMID 39085542).

What the Cited Literature Does Not Establish

The verified papers above are chemistry, microbiology and biophysics. They do not contain human clinical trials, human pharmacokinetics, dosing information or safety outcomes in people, and nothing on this page should be read as describing use in humans. The 2020 Journal of Medicinal Chemistry review discussed teixobactin as a step toward a new antibiotic class, which is a statement about research status rather than about clinical availability (PMID 32520557). Reported antibacterial activity for analogues in the chemistry papers was measured in laboratory assays (PMID 38116416, PMID 39344830).

How to read mechanism claims critically

1. Check whether a finding came from purified components, model membranes, whole bacteria or an animal; the strongest teixobactin mechanism data in this set came from membrane based spectroscopy (PMID 32503964).
2. Separate what was measured from what was proposed; the resistance argument appears in review discussion (PMID 39085542) while tolerance was measured in culture (PMID 41251371).
3. Note the organism; several findings here were specific to Enterococcus faecalis (PMID 37475106) or to engineered strains in comparator work (PMID 39254256).

Related Reading

Background on discovery, structure, analogue development and the wider research record is covered in the teixobactin overview.

References

• Sophisticated natural products as antibiotics (Nature, 2024)
• Prolonged exposure to teixobactin generates cross-tolerance to other cell wall-targeting antimicrobials in Enterococcus faecalis (Antimicrobial Agents and Chemotherapy, 2025)
• Teixobactin: A Paving Stone toward a New Class of Antibiotics? (Journal of Medicinal Chemistry, 2020)
• New Teixobactin Analogues with a Total Lactam Ring (ACS Medicinal Chemistry Letters, 2023)
• Synthesis and structure-activity relationships of teixobactin (Annals of the New York Academy of Sciences, 2020)
• Teixobactin "Swapmers" with l Tail Stereochemistry Retain Antibiotic Activity (The Journal of Organic Chemistry, 2024)
• Probing key elements of teixobactin-lipid II interactions in membranes (Chemical Science, 2018)
• The Mechanism of Action of Lysobactin (Journal of the American Chemical Society, 2016)
• At the Crossroads of Bioenergetics and Antibiotic Discovery (Biochemistry. Biokhimiia, 2020)
• Mode of action of teixobactins in cellular membranes (Nature Communications, 2020)
• An Engineered Nisin Analogue with a Hydrophobic Moiety Attached at Position 17 Selectively Inhibits Enterococcus faecium Strains (ACS Chemical Biology, 2024)
• The two-component system CroRS acts as a master regulator of cell envelope homeostasis to confer antimicrobial tolerance in the bacterial pathogen Enterococcus faecalis (Molecular Microbiology, 2023)